-
Vicasinabin (RG7774) is a
potent cannabinoid agonist which is
highly selective for the CB2
receptor subtype. It was
developed by
Roche as a potential...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...
- O-2220
Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3
QMPSB S-444,823 S-777,469 SER-601
Tedalinab URB-447
Vicasinabin VSN-16 WIN 55,212-2 WIN 56,098...